KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $12.0 million.

  • Organon's Change in Account Payables rose 10754.72% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.0 million, marking a year-over-year decrease of 34375.0%. This contributed to the annual value of -$157.0 million for FY2024, which is 19631.9% down from last year.
  • As of Q3 2025, Organon's Change in Account Payables stood at $12.0 million, which was up 10754.72% from $40.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Change in Account Payables ranged from a high of $1.1 billion in Q2 2021 and a low of -$349.0 million during Q1 2024
  • Its 5-year average for Change in Account Payables is $17.6 million, with a median of $4.0 million in 2021.
  • As far as peak fluctuations go, Organon's Change in Account Payables skyrocketed by 2685000.0% in 2021, and later crashed by 755000.0% in 2022.
  • Quarter analysis of 5 years shows Organon's Change in Account Payables stood at -$281.0 million in 2021, then surged by 130.6% to $86.0 million in 2022, then surged by 168.6% to $231.0 million in 2023, then tumbled by 74.89% to $58.0 million in 2024, then crashed by 79.31% to $12.0 million in 2025.
  • Its Change in Account Payables was $12.0 million in Q3 2025, compared to $40.0 million in Q2 2025 and -$149.0 million in Q1 2025.